ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 98 filers reported holding ADMA BIOLOGICS INC in Q4 2020. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $265,220 | -56.3% | 80,127 | -81.4% | 0.00% | – |
| Q4 2021 | $607,000 | +77.5% | 430,548 | +42.2% | 0.00% | – |
| Q3 2021 | $342,000 | -42.4% | 302,743 | -18.5% | 0.00% | -100.0% |
| Q2 2021 | $594,000 | +7.2% | 371,426 | +18.1% | 0.00% | 0.0% |
| Q1 2021 | $554,000 | +81.6% | 314,599 | +101.3% | 0.00% | 0.0% |
| Q4 2020 | $305,000 | +217.7% | 156,317 | +287.9% | 0.00% | – |
| Q3 2020 | $96,000 | +100.0% | 40,299 | +148.4% | 0.00% | – |
| Q2 2020 | $48,000 | -80.6% | 16,221 | -81.2% | 0.00% | -100.0% |
| Q1 2020 | $248,000 | -34.0% | 86,085 | -8.5% | 0.00% | -33.3% |
| Q4 2019 | $376,000 | +23.7% | 94,043 | +37.6% | 0.00% | +50.0% |
| Q3 2019 | $304,000 | +266.3% | 68,367 | +217.0% | 0.00% | +100.0% |
| Q2 2019 | $83,000 | +59.6% | 21,570 | +57.4% | 0.00% | 0.0% |
| Q1 2019 | $52,000 | +2500.0% | 13,700 | +1612.5% | 0.00% | – |
| Q4 2018 | $2,000 | -60.0% | 800 | -88.1% | 0.00% | – |
| Q3 2018 | $5,000 | – | 6,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $13,240,000 | 11.29% |
| Stonepine Capital Management, LLC | 7,661,690 | $25,360,194 | 8.50% |
| Altium Capital Management LP | 2,870,000 | $9,499,700 | 5.27% |
| Caligan Partners LP | 1,662,613 | $5,503,249 | 3.84% |
| AWM Investment Company, Inc. | 6,015,000 | $19,909,650 | 2.69% |
| Perceptive Advisors | 11,900,255 | $39,389,844 | 1.16% |
| EAM Investors, LLC | 1,035,752 | $3,428,339 | 0.67% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,169,500 | $3,871,045 | 0.60% |
| Magnetar Financial LLC | 7,074,722 | $23,417,330 | 0.46% |
| Virtus ETF Advisers LLC | 83,925 | $277,792 | 0.15% |